PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-49

  1. 4,525 Posts.
    lightbulb Created with Sketch. 110
    Well, I don't mind him writing about PAR as this should very well increase publicity and people who are comfortable with speculating on spec stocks will thus research PAR and decide accordingly.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.